- Home
- STKS vs MCRB Comparison
STKS vs MCRB Comparison
Compare STKS & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STKS | MCRB |
|---|---|---|
| Founded | 2004 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.8M | 41.2M |
| IPO Year | 2011 | 2015 |
Fundamental Metrics
Financial Performance| Metric | STKS | MCRB |
|---|---|---|
| Price | $1.16 | $1.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $4.45 | ★ $17.00 |
| AVG Volume (30 Days) | 24.3K | ★ 70.9K |
| Earning Date | 11-04-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $805,722,000.00 | $789,000.00 |
| Revenue This Year | $0.77 | N/A |
| Revenue Next Year | $7.93 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.66 | N/A |
| 52 Week Low | $1.07 | $1.68 |
| 52 Week High | $2.65 | $29.98 |
Technical Indicators
Market Signals| Indicator | STKS | MCRB |
|---|---|---|
| Relative Strength Index (RSI) | 38.47 | 25.98 |
| Support Level | $1.07 | N/A |
| Resistance Level | $1.95 | $9.53 |
| Average True Range (ATR) | 0.11 | 0.21 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 23.46 | 18.78 |
Price Performance
Historical ComparisonAbout STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through three segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.